What is the recommended dosage of methylergonovine (Methergine) following a postpartum hemorrhage?

Prepare for the CJE Maternity 1 Test. Study with engaging flashcards and multiple-choice questions, complete with hints and explanations for each question. Get ready to excel on your exam!

Multiple Choice

What is the recommended dosage of methylergonovine (Methergine) following a postpartum hemorrhage?

Explanation:
The recommended dosage of methylergonovine (Methergine) following a postpartum hemorrhage is indeed 0.2 mg administered intramuscularly (IM). This medication is an ergot alkaloid that is typically utilized to promote uterine contraction and reduce bleeding. The standard dosing facilitates effective management of uterine atony, which is a common cause of postpartum hemorrhage. Administering 0.2 mg ensures that the medication acts quickly to stimulate uterine tonicity, thus mitigating the risk of excessive blood loss. It is important to note that the medication should not be used in cases of hypertension or during pregnancy due to its vasoconstrictive properties, which can pose significant risks. Doses of methylergonovine higher than 0.2 mg are not standard for postpartum hemorrhage management due to the increased risk of adverse effects, including hypertension and complications related to over-contraction of the uterus. Therefore, the choice of 0.2 mg aligns with clinical guidelines and safety considerations, making it the appropriate dosage for treating this condition.

The recommended dosage of methylergonovine (Methergine) following a postpartum hemorrhage is indeed 0.2 mg administered intramuscularly (IM). This medication is an ergot alkaloid that is typically utilized to promote uterine contraction and reduce bleeding. The standard dosing facilitates effective management of uterine atony, which is a common cause of postpartum hemorrhage.

Administering 0.2 mg ensures that the medication acts quickly to stimulate uterine tonicity, thus mitigating the risk of excessive blood loss. It is important to note that the medication should not be used in cases of hypertension or during pregnancy due to its vasoconstrictive properties, which can pose significant risks.

Doses of methylergonovine higher than 0.2 mg are not standard for postpartum hemorrhage management due to the increased risk of adverse effects, including hypertension and complications related to over-contraction of the uterus. Therefore, the choice of 0.2 mg aligns with clinical guidelines and safety considerations, making it the appropriate dosage for treating this condition.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy